← Back to Clinical Trials
Recruiting NCT06381414

NCT06381414 Childhood Early Oral Aging Syndrome: Prevalence, Etiological Factors, and Consequences on Occlusion

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06381414
Status Recruiting
Phase
Sponsor University of Nove de Julho
Condition Aging
Study Type OBSERVATIONAL
Enrollment 183 participants
Start Date 2024-05-01
Primary Completion 2025-01-31

Eligibility & Interventions

Sex All sexes
Min Age 3 Years
Max Age 6 Years
Study Type OBSERVATIONAL
Interventions
Observation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 183 participants in total. It began in 2024-05-01 with a primary completion date of 2025-01-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The Early Oral Aging Syndrome (EOAS) is a broad concept concerning changes in oral health caused by systemic diseases of different origins, which are related to the current lifestyle in the pediatric population. Enamel defects associated with intrinsic and extrinsic factors promote the acceleration of dental structure loss in an early manner, causing impairment of function, aesthetics, and quality of life. In this context, this study aims to identify the prevalence of early childhood tooth wear and its severity using the Early Childhood Oral Aging Syndrome (EOAS) index as a diagnostic and epidemiological survey instrument, considering current alterations found in the pediatric population and verifying possible factors associated with each severity level. Participants aged 3 to 6 years old, enrolled in the pediatric dentistry clinic of the University Nove de Julho, will be selected. Children with imperfect amelogenesis and dentinogenesis, genetic syndromes, and undergoing orthodontic treatment will be excluded from the research. A questionnaire on general health, sleep quality, nutrition, hygiene habits, and parafunctional habits will be administered. Subsequently, a clinical examination will be conducted using the new Early Childhood Oral Aging Syndrome (EOAS) index with scores ranging from 0 to 3 to assess dental wear and dental management, and scores I to III that should be used concomitantly in cases of enamel defects presence, in addition to measuring the Vertical Dimension of Occlusion (VDO). EOAS scores will be computed and statistically analyzed for deciduous dentition with a significance level of P\<0.05.

Eligibility Criteria

Inclusion Criteria: * Children from three to six years of age with complete deciduous teeth; * Children regularly enrolled for dental care at the Uninove pediatric dentistry clinic Exclusion Criteria: * Children with amelogenesis or dentinogenesis imperfecta * Children undergoing orthodontic treatment * Children with a genetic syndrome

Frequently Asked Questions

Who can join the NCT06381414 clinical trial?

This trial is open to participants of all sexes, aged 3 Years or older, up to 6 Years, studying Aging. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06381414 currently recruiting?

Yes, NCT06381414 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Nove de Julho to inquire about joining.

Where is the NCT06381414 trial being conducted?

This trial is being conducted at São Paulo, Brazil.

Who is sponsoring the NCT06381414 clinical trial?

NCT06381414 is sponsored by University of Nove de Julho. The trial plans to enroll 183 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology